
Steven C. Pohnert
Examiner (ID: 19127, Phone: (571)272-3803 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1683, 1634 |
| Total Applications | 1248 |
| Issued Applications | 108 |
| Pending Applications | 205 |
| Abandoned Applications | 960 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15834787
[patent_doc_number] => 20200132675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => MULTIPLEXED INSTRUMENT-FREE BAR-CHART SPINCHIP INTEGRATED WITH NANOPARTICLE-MEDIATED APTASENSORS FOR VISUAL QUANTITATIVE DETECTION OF MULTIPLE PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 16/514521
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514521
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/514521 | MULTIPLEXED INSTRUMENT-FREE BAR-CHART SPINCHIP INTEGRATED WITH NANOPARTICLE-MEDIATED APTASENSORS FOR VISUAL QUANTITATIVE DETECTION OF MULTIPLE PATHOGENS | Jul 16, 2019 | Abandoned |
Array
(
[id] => 15210605
[patent_doc_number] => 20190367989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => SUPERVISED LEARNING METHODS FOR THE PREDICTION OF TUMOR RADIOSENSITIVITY TO PREOPERATIVE RADIOCHEMOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/513230
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16513230
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/513230 | SUPERVISED LEARNING METHODS FOR THE PREDICTION OF TUMOR RADIOSENSITIVITY TO PREOPERATIVE RADIOCHEMOTHERAPY | Jul 15, 2019 | Abandoned |
Array
(
[id] => 15899189
[patent_doc_number] => 20200149113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => DETECTION KIT AND DETECTION METHOD FOR UROTHELIAL CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 16/460546
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16460546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/460546 | Method for treating urothelial carcinoma | Jul 1, 2019 | Issued |
Array
(
[id] => 17815677
[patent_doc_number] => 11421276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Methods for diagnosing ischemia
[patent_app_type] => utility
[patent_app_number] => 16/454755
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 29005
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454755
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/454755 | Methods for diagnosing ischemia | Jun 26, 2019 | Issued |
Array
(
[id] => 17023516
[patent_doc_number] => 20210247387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => IMPROVED PROTEOMIC MULTIPLEX ASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/973734
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16973734
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/973734 | IMPROVED PROTEOMIC MULTIPLEX ASSAYS | Jun 18, 2019 | Pending |
Array
(
[id] => 15436285
[patent_doc_number] => 20200032326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => ULTRASENSITIVE ASSAYS FOR DETECTION OF SHORT NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/424989
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16424989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/424989 | ULTRASENSITIVE ASSAYS FOR DETECTION OF SHORT NUCLEIC ACIDS | May 28, 2019 | Abandoned |
Array
(
[id] => 15345875
[patent_doc_number] => 20200010829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => METHOD FOR SYNTHESIZING cDNA
[patent_app_type] => utility
[patent_app_number] => 16/425175
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16425175
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/425175 | METHOD FOR SYNTHESIZING cDNA | May 28, 2019 | Abandoned |
Array
(
[id] => 15024005
[patent_doc_number] => 20190323007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => Identification of a JAK2 Mutation in Polycythemia Vera
[patent_app_type] => utility
[patent_app_number] => 16/424976
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16424976
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/424976 | Identification of a JAK2 mutation in Polycythemia Vera | May 28, 2019 | Issued |
Array
(
[id] => 15178927
[patent_doc_number] => 20190360055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => METHOD OF QUANTIFYING DNA
[patent_app_type] => utility
[patent_app_number] => 16/420307
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16420307
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/420307 | METHOD OF QUANTIFYING DNA | May 22, 2019 | Abandoned |
Array
(
[id] => 19425071
[patent_doc_number] => 12084474
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Compositions and methods for chemical cleavage and deprotection of surface-bound oligonucleotides
[patent_app_type] => utility
[patent_app_number] => 16/411913
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28504
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16411913
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/411913 | Compositions and methods for chemical cleavage and deprotection of surface-bound oligonucleotides | May 13, 2019 | Issued |
Array
(
[id] => 14838879
[patent_doc_number] => 20190277840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => MEASURING METHOD AND MEASURING SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/397705
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397705
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/397705 | MEASURING METHOD AND MEASURING SYSTEM | Apr 28, 2019 | Abandoned |
Array
(
[id] => 19910474
[patent_doc_number] => 12286675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Epigenetic markers for the identification of blood sub-cells of type 1
[patent_app_type] => utility
[patent_app_number] => 16/379260
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 3157
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16379260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/379260 | Epigenetic markers for the identification of blood sub-cells of type 1 | Apr 8, 2019 | Issued |
Array
(
[id] => 14903835
[patent_doc_number] => 20190295683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => SYSTEMS AND METHODS FOR NON-HORMONAL FEMALE CONTRACEPTIVE DRUG TARGET IDENTIFICATION AND PRIORITIZATION
[patent_app_type] => utility
[patent_app_number] => 16/365339
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16365339
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/365339 | SYSTEMS AND METHODS FOR NON-HORMONAL FEMALE CONTRACEPTIVE DRUG TARGET IDENTIFICATION AND PRIORITIZATION | Mar 25, 2019 | Abandoned |
Array
(
[id] => 14535309
[patent_doc_number] => 20190203276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => METHODS OF DETECTING NUCLEIC ACIDS IN INDIVIDUAL CELLS AND OF IDENTIFYING RARE CELLS FROM LARGE HETEROGENEOUS CELL POPULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/294864
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16294864
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/294864 | METHODS OF DETECTING NUCLEIC ACIDS IN INDIVIDUAL CELLS AND OF IDENTIFYING RARE CELLS FROM LARGE HETEROGENEOUS CELL POPULATIONS | Mar 5, 2019 | Abandoned |
Array
(
[id] => 15039351
[patent_doc_number] => 20190330680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => METHODS AND SYSTEMS FOR DETECTING USUAL INTERSTITIAL PNEUMONIA
[patent_app_type] => utility
[patent_app_number] => 16/292573
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16292573
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/292573 | METHODS AND SYSTEMS FOR DETECTING USUAL INTERSTITIAL PNEUMONIA | Mar 4, 2019 | Abandoned |
Array
(
[id] => 16720470
[patent_doc_number] => 20210087617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => METHOD FOR DETECTING FLAVIVIRIDAE
[patent_app_type] => utility
[patent_app_number] => 16/499630
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16499630
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/499630 | METHOD FOR DETECTING FLAVIVIRIDAE | Feb 21, 2019 | Abandoned |
Array
(
[id] => 14407695
[patent_doc_number] => 20190169691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => HERITABLE EPIGENETIC MODIFICATIONS AS MARKERS OF CHEMOTHERAPY EXPOSURE
[patent_app_type] => utility
[patent_app_number] => 16/274579
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274579
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/274579 | HERITABLE EPIGENETIC MODIFICATIONS AS MARKERS OF CHEMOTHERAPY EXPOSURE | Feb 12, 2019 | Abandoned |
Array
(
[id] => 14836991
[patent_doc_number] => 20190276896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => METHODS AND MATERIALS FOR DETECTING GENE AMPLIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/272893
[patent_app_country] => US
[patent_app_date] => 2019-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16272893
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/272893 | METHODS AND MATERIALS FOR DETECTING GENE AMPLIFICATION | Feb 10, 2019 | Abandoned |
Array
(
[id] => 14535359
[patent_doc_number] => 20190203301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => CANCER PATIENT SELECTION FOR ADMINISTRATION OF WNT SIGNALING INHIBITORS USING RNF43 MUTATION STATUS
[patent_app_type] => utility
[patent_app_number] => 16/259419
[patent_app_country] => US
[patent_app_date] => 2019-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 245
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16259419
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/259419 | CANCER PATIENT SELECTION FOR ADMINISTRATION OF WNT SIGNALING INHIBITORS USING RNF43 MUTATION STATUS | Jan 27, 2019 | Abandoned |
Array
(
[id] => 16628708
[patent_doc_number] => 20210047361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => OLIGONUCLEOTIDE AND NUCLEIC ACID SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 16/964390
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964390 | OLIGONUCLEOTIDE AND NUCLEIC ACID SYNTHESIS | Jan 22, 2019 | Abandoned |